{"slug":"tesamorelin-skin","verification":{"valid":true,"entries":2,"head":"5c00c5fc342689e0ded81ed29ff8edb354035fbc46d2238df216ee1b84f116dd"},"energy":{"passes":2,"tokens_in":26854,"tokens_out":3058,"tokens_total":29912,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5c00c5fc342689e0ded81ed29ff8edb354035fbc46d2238df216ee1b84f116dd"},"provenance":[{"ts":"2026-06-29T23:14:03.687Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Skin\nSlug: tesamorelin-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down\",\"Why Tesamorelin might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"E","response":"{\n  \"slug\": \"tesamorelin-skin\",\n  \"title\": \"Tesamorelin for Skin: GH Axis Effects on Dermal Layers\",\n  \"body\": \"## What's breaking down\\n\\nSkin changes with age involve several layers. The epidermis thins. The dermis loses collagen and elastin fibers. Dermal thickness declines. These shifts reduce firmness and elasticity. Growth hormone and IGF-1 levels fall over decades. Lower GH and IGF-1 correlate with slower collagen production and reduced skin cell turnover. This creates a gap where breakdown outpaces repair. The result shows as wrinkles, sagging, and drier texture. No direct condition profile matched the slug, so the layers above come from known GH-skin biology.\\n\\n## Why Tesamorelin might help you\\n\\nTesamorelin is a growth hormone-releasing hormone analog. It signals the pituitary to release more of your own growth hormone. That GH travels to the liver and other tissues, raising IGF-1. IGF-1 and GH both appear in skin research. A 2003 review in Endocrine Reviews notes the importance of the GH and IGF systems in normal skin homeostasis. The review links GH to collagen synthesis and IGF to skin cell proliferation. These processes help maintain epidermal integrity.\\n\\nTherefore for you: If declining GH axis activity is part of your skin changes, Tesamorelin is discussed because it targets the repair side of the balance. It does not act as a topical cream or mask surface symptoms. Instead it raises systemic signals studied for tissue maintenance. If your skin layer involves reduced collagen turnover, the GH-IGF pathway offers one studied route. Human data on this exact link for skin remain absent, so the connection stays mechanistic.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tesamorelin addresses the GH axis and visceral fat layer. Any skin observations would flow from the same GH and IGF-1 increase that reduces visceral adipose tissue in trials. No multi-peptide stack applies here.\\n\\n## What the evidence actually shows\\n\\nHuman trials of tesamorel","tokens_in":26854,"tokens_out":3058,"cost":0,"prev":"genesis","hash":"c51bf857a79d1a368a86209ed50be574f322aaa4a373a34334bf9cdd493aa30f"},{"ts":"2026-07-17T02:42:26.420Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-skin","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c51bf857a79d1a368a86209ed50be574f322aaa4a373a34334bf9cdd493aa30f","hash":"5c00c5fc342689e0ded81ed29ff8edb354035fbc46d2238df216ee1b84f116dd"}]}